Acquisition

MA mergers and acquisitions deal handshake buyout
Pharma

Esperion to go private in potential $1.1B buyout by ArchiMed

After a March M&A move of its own, Esperion Therapeutics is itself being acquired and taken private by healthcare investment firm ArchiMed.
Fraiser Kansteiner May 1, 2026 11:26am
Biogen

Biogen lays out $5.6B to acquire Apellis

Mar 31, 2026 10:32am
Servier

Servier rounds out rare cancer offerings with $2.5B Day One buy

Mar 6, 2026 10:14am
more expensive
Favicon Fierce Biotech

China is no longer licensing 'bargain basement': analyst

Feb 24, 2026 5:07pm
MA
Favicon Fierce Biotech

4 trends driving biopharma M&A this year, per Bain

Jan 28, 2026 5:00pm
Maryland flag MD flag Maryland MD

Samsung Bio shells out $280M to secure first US production site

Dec 22, 2025 9:14am